Choose a language and wait for the translated text.
Shots:
nference has entered into a strategic collaboration with Novo Nordisk to advance research in cardiometabolic diseases incl. obesity, diabetes & CV disease
The collaboration will combine Novoโs clinical trial data with nferenceโs AI technology & federated healthcare data network to explore treatment effectiveness, safety, disease progression & long-term outcomes, with research programs aimed at clinical pharmacology, combination therapies & precision trials
The deal also includes a framework for venture co-creation to support AI-native companies addressing unmet needs in cardiometabolic health & healthy ageing
Ref: PR Newswire | Image: nference | Novo Nordisk | Press Release
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
The post nference Enters into a Strategic Collaboration with Novo to Advance Research in Cardiometabolic Disease appeared first on PharmaShots.